Form4insider filings, from the source

SEC Form 4 · accession 0000921895-19-000500

ENZON PHARMACEUTICALS, INC. · ENZN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Xstelos Corp.
10% Owner
Period of report
Feb 11, 2019
Accepted (ET)
Feb 14, 2019 · 9:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727510

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.01 par valueF1Feb 11, 2019P15,500$0.25A4,697,166D
Common Stock, $0.01 par valueF1Feb 11, 2019P10,000$0.25A4,707,166D
Common Stock, $0.01 par valueF1Feb 11, 2019P500$0.25A4,707,666D
Common Stock, $0.01 par valueF1Feb 11, 2019P10,000$0.25A4,717,666D
Common Stock, $0.01 par valueF1,F2Feb 11, 2019P10,000$0.25A1,569,523IBy Xstelos Corp.
Common Stock, $0.01 par valueF1,F2Feb 11, 2019P5,000$0.25A1,574,523IBy Xstelos Corp.
Common Stock, $0.01 par valueF1,F3holding———400,000IBy Couchman Family Fund

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses